Table of Contents Table of Contents
Previous Page  636 656 Next Page
Information
Show Menu
Previous Page 636 656 Next Page
Page Background

Table 2 – Uni- and multivariable logistic regression analyses assessing predicting the presence of lymph node invasion in 681 patients treated with radical prostatectomy and extended pelvic

lymph node dissection

Model 1

Model 2

Model 3

Model 4

Univariable analyses

Multivariable analyses

Multivariable analyses

Multivariable analyses

Multivariable analyses

OR (95% CI)

p

value

OR (95% CI)

p

value

OR (95% CI)

p

value

OR (95% CI)

p

value

OR (95% CI)

p

value

Preoperative PSA

1.11 (1.09–1.15)

<

0.001 1.08 (1.05–1.12)

<

0.001 1.08 (1.05–1.12)

<

0.001 1.09 (1.06–1.12)

<

0.001 1.08 (1.05–1.11)

<

0.001

Clinical stage

T1

1 (Ref.)

1 (Ref.)

1 (Ref.)

1 (Ref.)

1 (Ref.)

T2

3.75 (2.11–6.68)

<

0.001 2.27 (1.06–4.87)

0.03 2.27 (1.05–4.76)

0.03 2.01 (1.02–4.17)

0.04 2.06 (1.01–4.25)

0.049

T3

16.4 (7.6–35.4)

<

0.001 2.87 (1.03–8.12)

0.04 2.76 (1.03–7.87)

0.045 2.57 (1.00–7.16)

0.05 2.65 (0.94–7.37)

0.06

Biopsy Gleason grade group

1–2

1 (Ref.)

1 (Ref.)

1 (Ref.)

1 (Ref.)

1 (Ref.)

3

15.5 (7.7–29.9)

<

0.001 9.5 (4.4–21.1)

<

0.001 9.5 (4.3–20.8)

<

0.001 8.3 (3.8–18.2)

<

0.001 9.03 (4.1–19.9)

<

0.001

4–5

28.9 (14.5–47.6)

<

0.001 14.5 (6.6–29.9)

<

0.001 13.9 (6.2–31.5)

<

0.001 10.6 (4.8–23.5)

<

0.001 13.3 (5.8–29.8)

<

0.001

Percentage of positive cores

1.03 (1.02-1.04)

<

0.001 –

Percentage of positive cores with highest-grade PCa 1.03 (1.02–1.04)

<

0.001 1.02 (1.01–1.04)

<

0.001 1.02 (1.01–1.04)

<

0.001 1.03 (1.01–1.05)

0.001 1.02 (1.01–1.03)

0.01

Percentage of positive cores with lower-grade PCa

1.03 (1.01–1.04)

<

0.001 1.01 (0.99–1.03)

0.2

1.01 (0.98–1.03)

0.3

0.98 (0.95–1.02)

0.4

1.01 (0.99–1.04)

0.2

Maximum percentage of single core

involvement with highest-grade PCa

1.04 (1.03–1.04)

<

0.001 –

1.00 (0.98–1.01)

0.8

Maximum percentage of single core

involvement with lower-grade PCa

1.02 (1.01–1.03)

<

0.001 –

1.01 (0.99–1.03)

0.1

Percentage of tumor in biopsy cores

1.05 (1.04–1.06)

<

0.001 –

1.01 (0.99–1-04)

0.3

Percentage of highest-grade PCa in biopsy cores

1.05 (1.04–1.07)

<

0.001 –

1.01 (0.98–1.04)

0.4

Percentage of lower-grade PCa in biopsy cores

1.02 (1.00–1.05)

0.04 –

0.99 (0.97–1.02)

0.8

AUC of multivariable models (%)

91

91

91

91

AUC = area under the curve; OR = odds ratio; CI = confidence interval; PCa = prostate cancer; Ref. = reference.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 6 3 2 – 6 4 0

636